BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16791712)

  • 1. Blocking of striated muscle degeneration by serotonin in C. elegans.
    Carre-Pierrat M; Mariol MC; Chambonnier L; Laugraud A; Heskia F; Giacomotto J; Ségalat L
    J Muscle Res Cell Motil; 2006; 27(3-4):253-8. PubMed ID: 16791712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial hydrogen sulfide supplementation improves health in the
    Ellwood RA; Hewitt JE; Torregrossa R; Philp AM; Hardee JP; Hughes S; van de Klashorst D; Gharahdaghi N; Anupom T; Slade L; Deane CS; Cooke M; Etheridge T; Piasecki M; Antebi A; Lynch GS; Philp A; Vanapalli SA; Whiteman M; Szewczyk NJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33627403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans.
    Gaud A; Simon JM; Witzel T; Carre-Pierrat M; Wermuth CG; Ségalat L
    Neuromuscul Disord; 2004 Jun; 14(6):365-70. PubMed ID: 15145337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
    Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
    Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy.
    Giacomotto J; Brouilly N; Walter L; Mariol MC; Berger J; Ségalat L; Becker TS; Currie PD; Gieseler K
    Hum Mol Genet; 2013 Nov; 22(22):4562-78. PubMed ID: 23804750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy.
    Giacomotto J; Pertl C; Borrel C; Walter MC; Bulst S; Johnsen B; Baillie DL; Lochmüller H; Thirion C; Ségalat L
    Hum Mol Genet; 2009 Nov; 18(21):4089-101. PubMed ID: 19648295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.
    Waugh TA; Horstick E; Hur J; Jackson SW; Davidson AE; Li X; Dowling JJ
    Hum Mol Genet; 2014 Sep; 23(17):4651-62. PubMed ID: 24760771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-structural time-course study in the C. elegans model for Duchenne muscular dystrophy highlights a crucial role for sarcomere-anchoring structures and sarcolemma integrity in the earliest steps of the muscle degeneration process.
    Brouilly N; Lecroisey C; Martin E; Pierson L; Mariol MC; Qadota H; Labouesse M; Streichenberger N; Mounier N; Gieseler K
    Hum Mol Genet; 2015 Nov; 24(22):6428-45. PubMed ID: 26358775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle.
    Klymiuk N; Blutke A; Graf A; Krause S; Burkhardt K; Wuensch A; Krebs S; Kessler B; Zakhartchenko V; Kurome M; Kemter E; Nagashima H; Schoser B; Herbach N; Blum H; Wanke R; Aartsma-Rus A; Thirion C; Lochmüller H; Walter MC; Wolf E
    Hum Mol Genet; 2013 Nov; 22(21):4368-82. PubMed ID: 23784375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle.
    Ruegg UT; Nicolas-Métral V; Challet C; Bernard-Hélary K; Dorchies OM; Wagner S; Buetler TM
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S155-61. PubMed ID: 12206810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome changes during the initiation and progression of Duchenne muscular dystrophy in Caenorhabditis elegans.
    Hrach HC; O'Brien S; Steber HS; Newbern J; Rawls A; Mangone M
    Hum Mol Genet; 2020 Jun; 29(10):1607-1623. PubMed ID: 32227114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle strength deficiency and mitochondrial dysfunction in a muscular dystrophy model of
    Hewitt JE; Pollard AK; Lesanpezeshki L; Deane CS; Gaffney CJ; Etheridge T; Szewczyk NJ; Vanapalli SA
    Dis Model Mech; 2018 Dec; 11(12):. PubMed ID: 30396907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of endurance of DMD animal model using natural polyphenols.
    Sitzia C; Farini A; Colleoni F; Fortunato F; Razini P; Erratico S; Tavelli A; Fabrizi F; Belicchi M; Meregalli M; Comi G; Torrente Y
    Biomed Res Int; 2015; 2015():680615. PubMed ID: 25861640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced IGF signaling prevents muscle cell death in a Caenorhabditis elegans model of muscular dystrophy.
    Oh KH; Kim H
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19024-9. PubMed ID: 24191049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscular degeneration in the absence of dystrophin is a calcium-dependent process.
    Mariol MC; Ségalat L
    Curr Biol; 2001 Oct; 11(21):1691-4. PubMed ID: 11696327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
    Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
    J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.